A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia.

Anti malaria COVID-19 Dissolution Hydroxy chloroquine sulfate validation

Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
05 May 2020
Historique:
pubmed: 24 7 2020
medline: 24 7 2020
entrez: 24 7 2020
Statut: epublish

Résumé

Hydroxychloroquine sulfate is one of a large series of 4-aminoquinolines with antimalarial activity. Moreover, it is used for the treatment of rheumatoid arthritis. Sometimes Hydroxychloroquine sulfate is very effective for the treatment of autoimmune diseases. Based on the recent clinical experiments it is exploiting for the treatment of COVID-19, corona virus across the globe. A Reverse phase RP-HPLC method have been developed and validated as per the current ICH guidelines for estimation of Hydroxychloroquine sulfate tablets. As part of method validation specificity, linearity, precision and recovery parameters were verified. The concentration and area relationships were linear (R

Identifiants

pubmed: 32702733
doi: 10.21203/rs.3.pex-880/v2
pmc: PMC7336707
pii:
doi:

Types de publication

Preprint

Langues

eng

Auteurs

Classifications MeSH